Access cutting-edge diabetes mellitus treatment through this clinical trial at a research site in Oklahoma City. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Oklahoma City location
Preparing your pre-screening questions…
Access diabetes mellitus specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related diabetes mellitus treatment provided free
Check if you qualify for this diabetes mellitus clinical trial in Oklahoma City, OK
No-Cost Study Care
Local to Oklahoma City
Convenient for OK residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The study will investigate the effect of Dapagliflozin on atrial fibrillation (AF) burden. AF burden will be defined as the percent of time spent in AF over a 2-week period, assessed by noninvasive continuous heart rhythm monitoring at baseline and at 3 months, quality of life (QOL) and validated echocardiographic indices of atrial myopathy. This knowledge will enable us to study the therapeutic potential of SGLT2i as a novel adjunct treatment for patients with DM and AF. Patients with paroxysmal AF (AF that terminates spontaneously or with intervention within seven days of onset) and DM and randomize them to Dapagliflozin or placebo. Continuous heart rhythm monitoring patch for AF burden will be used, measure of QOL with the help of AF Effect on Quality-of-life survey and perform an echocardiogram with measurement of left atrial volume index, left atrial strain and atrial tissue dopplers. All measurements will be performed at baseline and at study completion. The central hypothesis is that SGLT2i will lead to reduced AF burden that will translate into improvement in QOL, and the underlying mechanism is improvement in atrial myopathy.
Sponsor: University of Oklahoma
Yes, this clinical trial (NCT05174052) has an active research site in Oklahoma City, OK that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for diabetes mellitus treatment options in Oklahoma City, OK, this clinical trial (NCT05174052) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Oklahoma City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced diabetes mellitus specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all diabetes mellitus clinical trials near you to find additional studies recruiting in your area.
See all essential tremor clinical trials recruiting in Oklahoma City — not just this study.
Browse Essential Tremor Trials in Oklahoma City →